The road ahead for chronic headache patients.
Martelletti
Paolo
P
Department of Medical Sciences, 2nd School of Medicine, University La Sapienza, Sant'Andrea Hospital, Rome, Italy. paolo.martelletti@uniroma1.it
D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000627:therapeutic use; D000928:Antidepressive Agents / Q000627:therapeutic use; D019274:Botulinum Toxins, Type A / Q000009:adverse effects / Q000494:pharmacology* / Q000627:therapeutic use*; D005632:Fructose / Q000031:analogs & derivatives / Q000627:therapeutic use; D020773:Headache Disorders / Q000188:drug therapy* / Q000503:physiopathology / Q000517:prevention & control*; D006801:Humans; D000077236:Topiramate
D000894:Anti-Inflammatory Agents, Non-Steroidal; D000928:Antidepressive Agents; D000077236:Topiramate; D005632:Fructose; D019274:Botulinum Toxins, Type A